{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:01:23Z","timestamp":1794330083423,"version":"4.9.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PID2023\\u2013148128OB-I00"],"award-info":[{"award-number":["PID2023\\u2013148128OB-I00"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Government of Catalonia Agency for Administration of University and Research Grants","doi-asserted-by":"publisher","award":["2021-SGR 00323"],"award-info":[{"award-number":["2021-SGR 00323"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espana Ministerio de Ciencia e Innovacion","doi-asserted-by":"publisher","award":["PDC2021\\u2013120758-I00"],"award-info":[{"award-number":["PDC2021\\u2013120758-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espana Ministerio de Ciencia e Innovacion","doi-asserted-by":"publisher","award":["PID2020\\u2013118296RB-I00"],"award-info":[{"award-number":["PID2020\\u2013118296RB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009410","name":"Universitat de Lleida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biopha.2026.119031","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:34:43Z","timestamp":1769157283000},"page":"119031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Targeting frataxin deficiency in DRG neurons and fibroblasts: omaveloxolone restores metabolic and iron balance to reduce ferroptosis"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6167-9801","authenticated-orcid":false,"given":"Marta","family":"Portillo-Carrasquer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4614-0581","authenticated-orcid":false,"given":"Arabela","family":"Sanz-Alc\u00e1zar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8208-8736","authenticated-orcid":false,"given":"Bego\u00f1a","family":"S\u00e1nchez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7815-5537","authenticated-orcid":false,"given":"Fabien","family":"Delaspre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1267-2491","authenticated-orcid":false,"given":"Maria","family":"Pazos-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5291-9053","authenticated-orcid":false,"given":"Luiza","family":"Oliveira-Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4604-9999","authenticated-orcid":false,"given":"Laia","family":"Castells-Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Tamarit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2795-7999","authenticated-orcid":false,"given":"Elisa","family":"Cabiscol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119031_bib1","first-page":"391","article-title":"Ueber degenerative Atrophie der spinalen Hinterstr\u00e4nge","volume":"26","author":"Friedreich","year":"1863","journal-title":"Arch. F. \u00fcR. Pathol. Anat. Und Physiol. Und F. \u00fcR. Klin. Med."},{"key":"10.1016\/j.biopha.2026.119031_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-010-0675-0","article-title":"Pathology and pathogenesis of sensory neuropathy in Friedreich\u2019s ataxia","volume":"120","author":"Morral","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2026.119031_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jnc.12317","article-title":"Clinical features of Friedreich\u2019s ataxia: classical and atypical phenotypes","volume":"126","author":"Parkinson","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2026.119031_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jns.2011.05.023","article-title":"Mortality in Friedreich Ataxia","volume":"307","author":"Tsou","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.biopha.2026.119031_bib5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich\u2019s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion","volume":"271","author":"Campuzano","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119031_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.24595","article-title":"Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia","volume":"79","author":"Galea","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2026.119031_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.838335","article-title":"Recent advances in the elucidation of frataxin biochemical function open novel perspectives for the treatment of Friedreich\u2019s Ataxia","volume":"16","author":"Monfort","year":"2022","journal-title":"Front Neurosci."},{"key":"10.1016\/j.biopha.2026.119031_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00018-023-05064-4","article-title":"Mitochondrial impairment, decreased sirtuin activity and protein acetylation in dorsal root ganglia in Friedreich Ataxia models","volume":"81","author":"Sanz-Alc\u00e1zar","year":"2023","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119031_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103339","article-title":"Deciphering the ferroptosis pathways in dorsal root ganglia of Friedreich ataxia models. The role of LKB1\/AMPK, KEAP1, and GSK3\u03b2 in the impairment of the NRF2 response","volume":"76","author":"Sanz-Alc\u00e1zar","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2026.119031_bib10","doi-asserted-by":"crossref","first-page":"9757","DOI":"10.1073\/pnas.0804261105","article-title":"The MCK mouse heart model of Friedreich\u2019s ataxia: Alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation","volume":"105","author":"Whitnall","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2026.119031_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102038","article-title":"Mechanisms of impaired mitochondrial homeostasis and NAD+ metabolism in a model of mitochondrial heart disease exhibiting redox active iron accumulation","volume":"46","author":"Chiang","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2026.119031_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.31083\/j.jin2301004","article-title":"Tissue iron in Friedreich Ataxia","volume":"23","author":"Koeppen","year":"2024","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.biopha.2026.119031_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/hmg\/ddi042","article-title":"Friedreich ataxia: the oxidative stress paradox","volume":"14","author":"Seznec","year":"2005","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2026.119031_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-021-04100-5","article-title":"Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations","volume":"79","author":"Medina-Carbonero","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119031_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104606","article-title":"Friedreich ataxia- pathogenesis and implications for therapies","volume":"132","author":"Delatycki","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2026.119031_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/jpet.118.252759","article-title":"Ferroptosis as a novel therapeutic target for Friedreich\u2019s Ataxia","volume":"369","author":"Cotticelli","year":"2019","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2026.119031_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205211","article-title":"Targeting NRF2 for the treatment of Friedreich\u2019s Ataxia: a comparison among drugs","volume":"20","author":"Petrillo","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119031_bib18","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1016\/j.ajpath.2017.08.021","article-title":"Molecular alterations in a mouse cardiac model of Friedreich Ataxia: an impaired Nrf2 response mediated via upregulation of Keap1 and activation of the Gsk3\u03b2 axis","volume":"187","author":"Anzovino","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2026.119031_bib19","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1089\/ars.2012.4537","article-title":"Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich\u2019s Ataxia YG8R mouse model","volume":"19","author":"Shan","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2026.119031_bib20","doi-asserted-by":"crossref","first-page":"14841","DOI":"10.1074\/jbc.M513737200","article-title":"Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2","volume":"281","author":"Salazar","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119031_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41419-020-2253-2","article-title":"Frataxin deficiency induces lipid accumulation and affects thermogenesis in brown adipose tissue","volume":"11","author":"Turchi","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2026.119031_bib22","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2026.119031_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and efficacy of omaveloxolone in Friedreich Ataxia (MOXIe study)","volume":"89","author":"Lynch","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2026.119031_bib24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fncel.2018.00188","article-title":"Novel Nrf2-inducer prevents mitochondrial defects and oxidative stress in Friedreich\u2019s Ataxia models","volume":"12","author":"Abeti","year":"2018","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.biopha.2026.119031_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.29286","article-title":"Efficacy of omaveloxolone in Friedreich\u2019s Ataxia: delayed-start analysis of the MOXIe extension","volume":"38","author":"Lynch","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2026.119031_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/acn3.660","article-title":"Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia","volume":"6","author":"Lynch","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.biopha.2026.119031_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/14737175.2024.2310617","article-title":"Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations","volume":"24","author":"Lynch","year":"2024","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.biopha.2026.119031_bib28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/mds.30070","article-title":"Omaveloxolone for the treatment of Friedreich Ataxia: efficacy, safety, and future perspectives","volume":"40","author":"Naghipour","year":"2025","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2026.119031_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116999","article-title":"Discovery of novel compounds as potent activators of Sirt3","volume":"73","author":"Reverdy","year":"2022","journal-title":"Bioorg. Med Chem."},{"key":"10.1016\/j.biopha.2026.119031_bib30","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1089\/ars.2009.2440","article-title":"Honokiol, a Multifunctional Antiangiogenic and Antitumor Agent","volume":"11","author":"Fried","year":"2009","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2026.119031_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-180126","article-title":"Honokiol alleviates cognitive deficits of Alzheimer\u2019s disease (PS1V97L) transgenic mice by activating mitochondrial SIRT3","volume":"64","author":"Li","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2026.119031_bib32","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/13872877251362185","article-title":"The effects of Honokiol on the liver of Alzheimer\u2019s disease mice by upregulating SIRT3","volume":"107","author":"Wang","year":"2025","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2026.119031_bib33","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202501428R","article-title":"Honokiol Targeting SIRT3: From Molecular Mechanisms to Therapeutic Opportunities","volume":"39","author":"Xiang","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2026.119031_bib34","doi-asserted-by":"crossref","first-page":"34082","DOI":"10.18632\/oncotarget.16133","article-title":"Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice","volume":"8","author":"Pillai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119031_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00414","article-title":"Sirt3 Ameliorates Oxidative Stress and Mitochondrial Dysfunction After Intracerebral Hemorrhage in Diabetic Rats","volume":"12","author":"Zheng","year":"2018","journal-title":"Front Neurosci."},{"key":"10.1016\/j.biopha.2026.119031_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178354","article-title":"Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich\u2019s Ataxia cardiomyopathy","volume":"12","author":"Stram","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2026.119031_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.952950","article-title":"Omaveloxolone inhibits IL-1\u03b2-induced chondrocyte apoptosis through the Nrf2\/ARE and NF-\u03baB signalling pathways in vitro and attenuates osteoarthritis in vivo","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2026.119031_bib38","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/ddt576","article-title":"Apoptotic cell death and altered calcium homeostasis caused by frataxin depletion in dorsal root ganglia neurons can be prevented by BH4 domain of Bcl-x L protein","volume":"23","author":"Mincheva-Tasheva","year":"2014","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2026.119031_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118553","article-title":"Leriglitazone improves iron homeostasis and ferroptotic markers in frataxin-deficient dorsal root ganglia neurons","volume":"192","author":"Portillo-Carrasquer","year":"2025","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.119031_bib40","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.freeradbiomed.2016.06.007","article-title":"Oxidative stress and altered lipid metabolism in Friedreich ataxia","volume":"100","author":"Tamarit","year":"2016","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.biopha.2026.119031_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105162","article-title":"PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia","volume":"148","author":"Rodr\u00edguez-Pascau","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2026.119031_bib42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11064-020-03020-3","article-title":"Calpain-inhibitors protect frataxin-deficient dorsal root ganglia neurons from loss of mitochondrial Na+\/Ca2+ exchanger, NCLX, and apoptosis","volume":"46","author":"Britti","year":"2021","journal-title":"Neurochem. Res"},{"key":"10.1016\/j.biopha.2026.119031_bib43","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1242\/dmm.030502","article-title":"Early cerebellar deficits in mitochondrial biogenesis and respiratory chain complexes in the KIKO mouse model of Friedreich ataxia","volume":"10","author":"Lin","year":"2017","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.biopha.2026.119031_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2019.103419","article-title":"Mitochondrial dysfunction in neurons in Friedreich\u2019s ataxia","volume":"102","author":"Stepanova","year":"2020","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.biopha.2026.119031_bib45","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0960-8966(00)00108-5","article-title":"Mitochondrial impairment of human muscle in Friedreich ataxia in vivo","volume":"10","author":"Vorgerd","year":"2000","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.biopha.2026.119031_bib46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/hmg\/9.2.275","article-title":"Clinical, biochemical and molecular genetic correlations in Friedreich\u2019s ataxia","volume":"9","author":"Bradley","year":"2000","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2026.119031_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/S0317167100006260","article-title":"Complex I and ATP content deficiency in lymphocytes from Friedreich\u2019s ataxia","volume":"36","author":"Heidari","year":"2009","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.biopha.2026.119031_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21218251","article-title":"Effect of mitochondrial and cytosolic FXN isoform expression on mitochondrial dynamics and metabolism","volume":"21","author":"Agr\u00f2","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119031_bib49","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1182\/blood.2020006987","article-title":"Defective palmitoylation of transferrin receptor triggers iron overload in Friedreich ataxia fibroblasts","volume":"137","author":"Petit","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2026.119031_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101483","article-title":"Identification of Frataxin as a regulator of ferroptosis","volume":"32","author":"Du","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2026.119031_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom10111551","article-title":"Ferroptosis in Friedreich\u2019s Ataxia: a metal-induced neurodegenerative disease","volume":"10","author":"La Rosa","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2026.119031_bib52","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3390\/biom10111489","article-title":"An overview of the ferroptosis hallmarks in Friedreich\u2019s Ataxia","volume":"10","author":"Turchi","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2026.119031_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101791","article-title":"The Nrf2 induction prevents ferroptosis in Friedreich\u2019s Ataxia","volume":"38","author":"La Rosa","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2026.119031_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004253","article-title":"Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia","volume":"4","author":"Paupe","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2026.119031_bib55","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s40120-025-00752-8","article-title":"Managing aminotransferase elevations in patients with Friedreich Ataxia treated with omaveloxolone: a review and expert opinion on use considerations","volume":"14","author":"Perlman","year":"2025","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.biopha.2026.119031_bib56","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/cns.13053","article-title":"SIRT3 activator honokiol ameliorates surgery\/anesthesia-induced cognitive decline in mice through anti-oxidative stress and anti-inflammatory in hippocampus","volume":"25","author":"Ye","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2026.119031_bib57","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.bbagen.2016.07.026","article-title":"Characterization of novel small-molecule NRF2 activators: Structural and biochemical validation of stereospecific KEAP1 binding","volume":"1860","author":"Huerta","year":"2016","journal-title":"Biochim. Et. Biophys. Acta (BBA) Gen. Subj."},{"key":"10.1016\/j.biopha.2026.119031_bib58","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1089\/ars.2017.7342","article-title":"Transcriptional Regulation by Nrf2","volume":"29","author":"Tonelli","year":"2018","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2026.119031_bib59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mas.21375","article-title":"Protein carbonylation: Proteomics, specificity and relevance to aging","volume":"33","author":"Cabiscol","year":"2014","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.biopha.2026.119031_bib60","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/hmg\/ddi214","article-title":"Frataxin interacts functionally with mitochondrial electron transport chain proteins","volume":"14","author":"Gonz\u00e1lez-Cabo","year":"2005","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2026.119031_bib61","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41419-023-06320-y","article-title":"Human frataxin, the Friedreich ataxia deficient protein, interacts with mitochondrial respiratory chain","volume":"14","author":"Davide","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2026.119031_bib62","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.276.5319.1709","article-title":"Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin","volume":"276","author":"Babcock","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119031_bib63","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1021\/bi500532e","article-title":"Human frataxin activates Fe-S cluster biosynthesis by facilitating sulfur transfer chemistry","volume":"53","author":"Bridwell-Rabb","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2026.119031_bib64","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1038\/ncomms6686","article-title":"Mammalian frataxin directly enhances sulfur transfer of NFS1 persulfide to both ISCU and free thiols","volume":"6","author":"Parent","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119031_bib65","article-title":"Cross-regulation of [2Fe-2S] cluster synthesis by ferredoxin-2 and frataxin","author":"Want","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119031_bib66","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/s41467-019-09989-y","article-title":"Structure of the human frataxin-bound iron-sulfur cluster assembly complex provides insight into its activation mechanism","volume":"10","author":"Fox","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119031_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11470-9","article-title":"Physiologically relevant reconstitution of iron-sulfur cluster biosynthesis uncovers persulfide-processing functions of ferredoxin-2 and frataxin","volume":"10","author":"Gervason","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119031_bib68","doi-asserted-by":"crossref","first-page":"10559","DOI":"10.1038\/s41467-024-54585-4","article-title":"Two-stage binding of mitochondrial ferredoxin-2 to the core iron-sulfur cluster assembly complex","volume":"15","author":"Steinhilper","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119031_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1359618","article-title":"Emerging antioxidant therapies in Friedreich\u2019s ataxia","volume":"15","author":"Edzeamey","year":"2024","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2026.119031_bib70","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2015.01.010","article-title":"Iron regulatory protein 1 sustains mitochondrial iron loading and function in frataxin deficiency","volume":"21","author":"Martelli","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2026.119031_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.abb.2006.08.005","article-title":"Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion","volume":"454","author":"Osburn","year":"2006","journal-title":"Arch. Biochem Biophys."},{"key":"10.1016\/j.biopha.2026.119031_bib72","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.3390\/ijms21103410","article-title":"Analysis of putative epigenetic regulatory elements in the FXN genomic locus","volume":"21","author":"Fern\u00e1ndez-Fr\u00edas","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119031_bib73","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s40120-025-00749-3","article-title":"Safety monitoring of omaveloxolone in Friedreich Ataxia: results from one year of clinical treatment","volume":"14","author":"Gunther","year":"2025","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.biopha.2026.119031_bib74","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2147\/DDDT.S193889","article-title":"Pharmacokinetics and pharmacodynamics of the novel NrF2 activator omaveloxolone in primates","volume":"13","author":"Reisman","year":"2019","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.biopha.2026.119031_bib75","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/cancers12010048","article-title":"Honokiol: A Review of Its Anticancer Potential and Mechanisms","volume":"12","author":"Ong","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2026.119031_bib76","doi-asserted-by":"crossref","first-page":"11989","DOI":"10.1038\/s41598-017-12095-y","article-title":"Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts","volume":"7","author":"Huang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119031_bib77","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cmet.2015.10.013","article-title":"Mitochondrial SIRT3 mediates adaptive responses of neurons to exercise and metabolic and excitatory challenges","volume":"23","author":"Cheng","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2026.119031_bib78","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1038\/ncomms7656","article-title":"Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3","author":"Pillai","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119031_bib79","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1128\/MCB.01636-07","article-title":"Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation","volume":"27","author":"Lombard","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2026.119031_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023295","article-title":"Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity","volume":"6","author":"Finley","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2026.119031_bib81","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature08778","article-title":"SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation","volume":"464","author":"Hirschey","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119031_bib82","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.tibs.2010.07.003","article-title":"Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling","volume":"35","author":"Verdin","year":"2010","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.biopha.2026.119031_bib83","article-title":"NRF2-mediated SIRT3 induction protects hepatocytes from ER stress-induced liver injury","volume":"36","author":"Kim","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2026.119031_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2022.129381","article-title":"Mitigation of honokiol on fluoride-induced mitochondrial oxidative stress, mitochondrial dysfunction, and cognitive deficits through activating AMPK\/PGC-1\u03b1\/Sirt3","volume":"437","author":"Wang","year":"2022","journal-title":"J. Hazard Mater."},{"key":"10.1016\/j.biopha.2026.119031_bib85","article-title":"Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK\/PGC-1\u03b1\/Apoptosis Signaling Pathway","volume":"11","author":"Li","year":"2022","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.biopha.2026.119031_bib86","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1128\/MCB.00118-16","article-title":"AMPK facilitates nuclear accumulation of Nrf2 by phosphorylating at Serine 550","volume":"36","author":"Joo","year":"2016","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2026.119031_bib87","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.bcp.2009.12.011","article-title":"AMPK-mediated GSK3beta inhibition by isoliquiritigenin contributes to protecting mitochondria against iron-catalyzed oxidative stress","volume":"79","author":"Choi","year":"2010","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2026.119031_bib88","article-title":"PGC-1\u03b1 attenuates hydrogen peroxide-induced apoptotic cell death by upregulating Nrf-2 via GSK3\u03b2 inactivation mediated by activated p38 in HK-2 Cells","volume":"7","author":"Choi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119031_bib89","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1","volume":"98","author":"Wu","year":"1999","journal-title":"Cell"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:13:00Z","timestamp":1773990780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":89,"alternative-id":["S0753332226000636"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119031","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting frataxin deficiency in DRG neurons and fibroblasts: omaveloxolone restores metabolic and iron balance to reduce ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119031"}}